US Patent Issued to The Trustees of the University of Pennsylvania on Sept. 23 for "Blood biomarker that predicts persistent cognitive dysfunction after concussion" (Delaware Inventor)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,422,433, issued on Sept. 23, was assigned to The Trustees of the University of Pennsylvania (Philadelphia).

"Blood biomarker that predicts persistent cognitive dysfunction after concussion" was invented by Robert Siman (Wilmington, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to methods for providing prognosis, diagnosis, and treatment of a mild traumatic brain injury (mTBI) in a computed tomography (CT)-negative subject. The invention further relates to monitoring the severity of brain damage resulting from TBI in a subject and determining the prognosis of a subject that has suffered from mTBI. This invention also relates ...